Non-Hodgkin's Lymphoma — Selection of Treatment on the Basis of Histologic Type

Publisher Website
Google Scholar
Abstract
THE management of patients with malignant lymphomas has undergone considerable change during the past 10 years. As a result of advances in diagnostic and therapeutic methods, treatment results have dramatically improved for patients with Hodgkin's disease.1 , 2 The situation is not the same for patients with lymphomas other than Hodgkin's disease, the so-called non-Hodgkin's lymphomas.3 Problems in this field are reflected by the continued proposals of new histopathologic classifications and nomenclature.4 5 6 7 In part, this is due to new knowledge and concepts of the function of the lymphoid system. However, the search for new classifications and clinico-pathologic correlations is also motivated by . . .